Biomea Fusion (BMEA)

Last close As at 21/01/2025

0.00 (0.00%)

Market capitalisation

Biomea Fusion is a US-based clinical-stage biopharmaceutical company focussed on the development of novel covalent small molecules for the treatment of metabolic diseases and genetically defined cancers.

Sector

Healthcare

Equity Analyst

Key Management

  • Thomas Butler

    Founder, Chairman & CEO

  • Franco Valle

    Chief Financial Officer

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free